West Pharmaceutical Services Inc (WST)
355.64
+1.53
(+0.43%)
USD |
NYSE |
May 17, 16:00
355.59
-0.05
(-0.01%)
After-Hours: 20:00
West Pharmaceutical Services Cash from Investing (Quarterly): -90.60M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -90.60M |
| December 31, 2023 | -108.80M |
| September 30, 2023 | -95.70M |
| June 30, 2023 | -82.10M |
| March 31, 2023 | -82.10M |
| December 31, 2022 | -94.80M |
| September 30, 2022 | -59.10M |
| June 30, 2022 | -66.00M |
| March 31, 2022 | -68.30M |
| December 31, 2021 | -77.40M |
| September 30, 2021 | -65.30M |
| June 30, 2021 | -55.90M |
| March 31, 2021 | -54.50M |
| December 31, 2020 | -57.60M |
| September 30, 2020 | -49.10M |
| June 30, 2020 | -40.90M |
| March 31, 2020 | -31.90M |
| December 31, 2019 | -120.60M |
| September 30, 2019 | -31.60M |
| June 30, 2019 | -47.10M |
| March 31, 2019 | -28.70M |
| December 31, 2018 | -28.60M |
| September 30, 2018 | -26.50M |
| June 30, 2018 | -17.00M |
| March 31, 2018 | -28.70M |
| Date | Value |
|---|---|
| December 31, 2017 | -29.40M |
| September 30, 2017 | -34.00M |
| June 30, 2017 | -35.50M |
| March 31, 2017 | -34.70M |
| December 31, 2016 | -46.70M |
| September 30, 2016 | -47.90M |
| June 30, 2016 | -42.60M |
| March 31, 2016 | -38.60M |
| December 31, 2015 | -43.90M |
| September 30, 2015 | -29.50M |
| June 30, 2015 | -25.50M |
| March 31, 2015 | -30.60M |
| December 31, 2014 | -26.30M |
| September 30, 2014 | -20.70M |
| June 30, 2014 | -21.40M |
| March 31, 2014 | -35.60M |
| December 31, 2013 | -38.90M |
| September 30, 2013 | -29.10M |
| June 30, 2013 | -24.20M |
| March 31, 2013 | -57.70M |
| December 31, 2012 | -22.70M |
| September 30, 2012 | -25.50M |
| June 30, 2012 | -35.90M |
| March 31, 2012 | -31.90M |
| December 31, 2011 | -36.30M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-120.60M
Minimum
Dec 2019
-31.60M
Maximum
Sep 2019
-68.97M
Average
-65.65M
Median
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp | -285.00M |
| Intuitive Surgical Inc | -128.50M |
| Masimo Corp | -18.90M |
| Merit Medical Systems Inc | -22.05M |
| Insulet Corp | -24.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 118.20M |
| Cash from Financing (Quarterly) | -271.00M |
| Free Cash Flow | 386.10M |
| Free Cash Flow Per Share (Quarterly) | 0.3715 |
| Free Cash Flow to Equity (Quarterly) | 28.20M |
| Free Cash Flow to Firm (Quarterly) | 27.60M |
| Free Cash Flow Yield | 1.45% |